PUBLIC COMPANY

$TVRDTvardi Therapeutics, Inc.

Sugar Land, TX, USupdated 1mo ago

SEC EDGAR Yahoo Finance

community read0 votes

pipeline

2

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 11Phase 2

Phase 2

TTI-101

Metastatic Hepatocellular Carcinoma (HCC)

Phase 1

TTI-109

Fibrosis

Upcoming

no upcoming catalysts on record

Recent

(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Tvardi Therapeutics, Inc. jobs →

News

no news has mentioned this company yet

$TVRD

Data sources

SEC EDGAR

last refreshed 47m ago

Found something off?

Active trials

phase2A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinomarecruitingn=193
phase2Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosiscompletedn=100
phase1Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancerscompletedn=64
phase1Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancerterminatedn=6

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Insider activity

source: SEC Form 4

routine RSU / option mechanics (4)

Jan 29, 26grantO'Brien Stephen Paul · Principal Accounting Officer15,000 sh
Jan 29, 26grantConn Avi Daniel · Chief Financial Officer45,000 sh
Jan 29, 26grantKauh John Saewook M.D. · Chief Medical Officer45,000 sh
Jan 29, 26grantAlibhai Imran Nizamudin · Chief Executive Officer115,000 sh